Our observations support a model in which overexpression of USP9X in breast cancer results in elevated CEP131 protein, which, in turn, leads to centrosome amplification and genome instability, and eventually contributes to the development/progression of breast cancer. This evidence concerns the gene CEP131 and breast carcinoma.